-
1
-
-
0000417337
-
Molybdenum iron-sulfur flavin hydroxylases and related enzymes
-
Boyer, P. D., editor, Academic Press, New York
-
Bray, R. C. Molybdenum iron-sulfur flavin hydroxylases and related enzymes. In The enzymes XII. (Boyer, P. D., editor), Academic Press, New York, 300-419 (1975).
-
(1975)
The Enzymes XII
, pp. 300-419
-
-
Bray, R.C.1
-
2
-
-
0017122896
-
Degradation of purines and pyrimidines by microorganisms
-
Vogels, G. D. & van der Drift, C. Degradation of purines and pyrimidines by microorganisms. Bacteriol. Rev. 40, 403-468 (1976).
-
(1976)
Bacteriol. Rev
, vol.40
, pp. 403-468
-
-
Vogels, G.D.1
Van Der Drift, C.2
-
3
-
-
0000414562
-
Molybdenum-containing hydroxylases: Xanthine oxidase, aldehyde oxidase, and sulfite oxidase
-
(Spiro, T. G., editor) Wiley-Interscience, New York
-
Hille, R. & Massey, V. Molybdenum-containing hydroxylases: Xanthine oxidase, aldehyde oxidase, and sulfite oxidase. In Molybdenum Enzymes. Vol. 7 (Spiro, T. G., editor). Wiley-Interscience, New York, 443-518 (1985).
-
(1985)
Molybdenum Enzymes
, vol.7
, pp. 443-518
-
-
Hille, R.1
Massey, V.2
-
4
-
-
0036153761
-
Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus
-
DOI 10.1016/S0969-2126(01)00697-9, PII S0969212601006979
-
Truglio, J. J., Theis, K., Leimkuler, S., Rappa, R., Rajagopalan, K. V. & Kisker, C. Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus. Structure 10, 115-125 (2002). (Pubitemid 34112616)
-
(2002)
Structure
, vol.10
, Issue.1
, pp. 115-125
-
-
Truglio, J.J.1
Theis, K.2
Leimkuhler, S.3
Rappa, R.4
Rajagopalan, K.V.5
Kisker, C.6
-
5
-
-
0028069815
-
The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury
-
Nishino, T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J. Biochem. (Tokyo) 116, 1-6 (1994). (Pubitemid 24230774)
-
(1994)
Journal of Biochemistry
, vol.116
, Issue.1
, pp. 1-6
-
-
Nishino, T.1
-
6
-
-
0029347181
-
Flavoprotein structure and mechanism 4. Xanthine oxidase and xanthine dehydrogenase
-
Hille, R. & Nishino, T. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J. 9, 995-1003 (1995).
-
(1995)
FASEB J.
, vol.9
, pp. 995-1003
-
-
Hille, R.1
Nishino, T.2
-
7
-
-
0000273676
-
The mononuclear molybdenum enzymes
-
Hille, R. The mononuclear molybdenum enzymes. Chem. Rev. 96, 2757-2816 (1996). (Pubitemid 126641117)
-
(1996)
Chemical Reviews
, vol.96
, Issue.7
, pp. 2757-2816
-
-
Hille, R.1
-
8
-
-
0034718556
-
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion
-
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T. & Pai, E. F. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion. Proc. Natl. Acad. Sci. U. S. A. 97, 10723-10728 (2000).
-
(2000)
Proc. Natl. Acad. Sci. U. S. A
, vol.97
, pp. 10723-10728
-
-
Enroth, C.1
Eger, B.T.2
Okamoto, K.3
Nishino, T.4
Nishino, T.5
Pai, E.F.6
-
9
-
-
0002294206
-
Potentiation by inhibition of drug degradation: 6-substituted purines and xanthine oxidase
-
Elion, G. B., Callahan, S., Nathan, H., Bieber, S., Rundles, R. W. & Hitchings, G. H. Potentiation by inhibition of drug degradation: 6-substituted purines and xanthine oxidase. Biochem. Pharmacol. 12, 85-93 (1963).
-
(1963)
Biochem. Pharmacol
, vol.12
, pp. 85-93
-
-
Elion, G.B.1
Callahan, S.2
Nathan, H.3
Bieber, S.4
Rundles, R.W.5
Hitchings, G.H.6
-
10
-
-
46749134762
-
Mechanism of inhibition of xanthine oxidoreductase by allopurinol: Crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol
-
DOI 10.1080/15257770802146577, PII 794699692
-
Okamoto, K., Eger, B. T., Nishino, T., Pai, E. F. & Nishino, T. Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol. Nucleosides Nucleotides Nucleic Acids. 27, 888-93 (2008). (Pubitemid 351948548)
-
(2008)
Nucleosides, Nucleotides and Nucleic Acids
, vol.27
, Issue.6-7
, pp. 888-893
-
-
Okamoto, K.1
Eger, B.T.2
Nishino, T.3
Pai, E.F.4
Nishino, T.5
-
11
-
-
36949002370
-
Crystal structure of human xanthine oxidoreductase mutant
-
(Tokyo)
-
Yamaguchi, Y., Matsumura, T., Ichida, K., Okamoto, K. & Nishino, T. Crystal structure of human xanthine oxidoreductase mutant, Glu803Val. J. Biochem. (Tokyo). 141, 513-524 (2007).
-
(2007)
Glu803Val. J. Biochem.
, vol.141
, pp. 513-524
-
-
Yamaguchi, Y.1
Matsumura, T.2
Ichida, K.3
Okamoto, K.4
Nishino, T.5
-
12
-
-
78650097787
-
Crystal structure of rat D428A mutant, urate bound form
-
Okamoto, K., Kawaguchi, Y., Eger, B. T., Pai, E. F. & Nishino, T. Crystal structure of rat D428A mutant, urate bound form. J. Am. Chem. Soc. 132, 17080-17083 (2010).
-
(2010)
J. Am. Chem. Soc
, vol.132
, pp. 17080-17083
-
-
Okamoto, K.1
Kawaguchi, Y.2
Eger, B.T.3
Pai, E.F.4
Nishino, T.5
-
13
-
-
0027205542
-
Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents
-
Osada, Y. et al. Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents. Eur. J. Pharmacol. 241, 183-188 (1993). (Pubitemid 23272878)
-
(1993)
European Journal of Pharmacology
, vol.241
, Issue.2-3
, pp. 183-188
-
-
Osada, Y.1
Tsuchimoto, M.2
Fukushima, H.3
Takahashi, K.4
Kondo, S.5
Hasegawa, M.6
Komoriya, K.7
-
14
-
-
0027745255
-
Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees
-
DOI 10.1016/0014-2999(93)90033-E
-
Komoriya, K. et al. Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees. Eur. J. Pharmacol. 250, 455-460 (1993). (Pubitemid 24010981)
-
(1993)
European Journal of Pharmacology
, vol.250
, Issue.3
, pp. 455-460
-
-
Komoriya, K.1
Osada, Y.2
Hasegawa, M.3
Horiuchi, H.4
Kondo, S.5
Couch, R.C.6
Griffin, T.B.7
-
15
-
-
28944437578
-
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
-
DOI 10.1056/NEJMoa050373
-
Becker, M. A. et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N. Engl. J. Med. 353, 2450-2461 (2005). (Pubitemid 41781828)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.23
, pp. 2450-2461
-
-
Becker, M.A.1
Schumacher Jr., H.R.2
Wortmann, R.L.3
MacDonald, P.A.4
Eustace, D.5
Palo, W.A.6
Streit, J.7
Joseph-Ridge, N.8
-
16
-
-
79151481493
-
Gout therapeutics: New drugs for an old disease
-
Burns, C. M. & Wortmann, R. L. Gout therapeutics: new drugs for an old disease. Lancet 377, 165-177 (2011).
-
(2011)
Lancet
, vol.377
, pp. 165-177
-
-
Burns, C.M.1
Wortmann, R.L.2
-
17
-
-
0037449776
-
An extremely potent inhibitor of xanthine oxidoreductase: Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
-
DOI 10.1074/jbc.M208307200
-
Okamoto K, Eger, B. T., Nishino, T., Kondo, S., Pai, E. F. & Nishino, T. An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition. J. Biol. Chem. 278, 1848-1855 (2003). (Pubitemid 36801423)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.3
, pp. 1848-1855
-
-
Okamoto, K.1
Eger, B.T.2
Nishino, T.3
Kondo, S.4
Pai, E.F.5
Nishino, T.6
-
18
-
-
14444281534
-
Viracept (nelfinavir mesylate, AG1343): A potent, orally bioavailable inhibitor of HIV-1 protease
-
DOI 10.1021/jm9704098
-
Kaldor, S. W. et al. Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease. J. Med. Chem. 40, 3979-3985 (1997). (Pubitemid 27512316)
-
(1997)
Journal of Medicinal Chemistry
, vol.40
, Issue.24
, pp. 3979-3985
-
-
Kaldor, S.W.1
Kalish, V.J.2
Davies II, J.F.3
Shetty, B.V.4
Fritz, J.E.5
Appelt, K.6
Burgess, J.A.7
Campanale, K.M.8
Chirgadze, N.Y.9
Clawson, D.K.10
Dressman, B.A.11
Hatch, S.D.12
Khalil, D.A.13
Kosa, M.B.14
Lubbehusen, P.P.15
Muesing, M.A.16
Patick, A.K.17
Reich, S.H.18
Su, K.S.19
Tatlock, J.H.20
more..
-
19
-
-
0032996584
-
Development of neuraminidase inhibitors as anti-influenza virus drugs
-
DOI 10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0. CO;2-6
-
Varghese, J. N. Development of neuraminidase inhibitors as anti-influenza virus drugs. Drug Develop. Res. 46, 176-196 (1999). (Pubitemid 29258917)
-
(1999)
Drug Development Research
, vol.46
, Issue.3-4
, pp. 176-196
-
-
Varghese, J.N.1
-
20
-
-
0034665713
-
Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase
-
Schindler, T. W., Bornmann, P., Pellicena, W. T., Miller, B., Clarkson & J. Kuriyan. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 289, 1938-1942 (2000).
-
(2000)
Science
, vol.289
, pp. 1938-1942
-
-
Schindler, T.W.1
Bornmann, P.2
Pellicena, W.T.3
Clarkson, M.B.4
Kuriyan, J.5
-
21
-
-
0037212102
-
LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites
-
DOI 10.1016/S1093-3263(02)00164-X, PII S109332630200164X
-
Venkatachalam, C. M., Jiang, X., Oldfield, T. & Waldman, M. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J. Mol. Graph. Model. 21, 289-307 (2003). (Pubitemid 35441326)
-
(2003)
Journal of Molecular Graphics and Modelling
, vol.21
, Issue.4
, pp. 289-307
-
-
Venkatachalam, C.M.1
Jiang, X.2
Oldfield, T.3
Waldman, M.4
-
22
-
-
30344440627
-
-
University of California San Francisco
-
Case, D. A. et al. AMBER 11, University of California, San Francisco (2010).
-
(2010)
AMBER
, pp. 11
-
-
Case, D.A.1
-
23
-
-
0013926855
-
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase
-
Elion, G. B., Kovensky, A. & Hitchings, G. H. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem. Pharmacol. 15, 863-880 (1966).
-
(1966)
Biochem. Pharmacol
, vol.15
, pp. 863-880
-
-
Elion, G.B.1
Kovensky, A.2
Hitchings, G.H.3
-
24
-
-
13444257733
-
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase
-
DOI 10.1016/j.lfs.2004.10.031
-
Takano, Y. et al. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Life Sci. 76, 1835-47 (2005). (Pubitemid 40215224)
-
(2005)
Life Sciences
, vol.76
, Issue.16
, pp. 1835-1847
-
-
Takano, Y.1
Hase-Aoki, K.2
Horiuchi, H.3
Zhao, L.4
Kasahara, Y.5
Kondo, S.6
Becker, M.A.7
-
25
-
-
0038757593
-
Recombinant Rhodobacter capsulatus xanthine dehydrogenase, a useful model system for the characterization of protein variants leading to xanthinuria I in humans
-
DOI 10.1074/jbc.M303091200
-
Leimküler, S., Hodson, R., George, G. N. & Rajagopalan, K. V. Recombinant Rhodobacter capsulatus xanthine dehydrogenase, a useful model system for the characterization of protein variants leading to xanthinuria I in humans. J. Biol. Chem. 278, 20802-20811 (2003). (Pubitemid 36806385)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.23
, pp. 20802-20811
-
-
Leimkuhler, S.1
Hodson, R.2
George, G.N.3
Rajagopalan, K.V.4
-
26
-
-
0014669771
-
Studies on milk xanthine oxidase. Some spectral and kinetic properties
-
Massey, V., Brumby, P. E. & Komai, H. Studies on milk xanthine oxidase. Some spectral and kinetic properties. J. Biol. Chem. 244, 1682-1691 (1969).
-
(1969)
J. Biol. Chem
, vol.244
, pp. 1682-1691
-
-
Massey, V.1
Brumby, P.E.2
Komai, H.3
-
28
-
-
33750587438
-
Molecular dynamics with coupling to an external bath
-
Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., Dinola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684-3690 (1984).
-
(1984)
J. Chem. Phys
, vol.81
, pp. 3684-3690
-
-
Berendsen, H.J.C.1
Postma, J.P.M.2
Van Gunsteren, W.F.3
Dinola, A.4
Haak, J.R.5
-
29
-
-
33846823909
-
Particle mesh Ewald: An nlog(N) method for Ewald sums in large systems
-
Darden, T. D. York & Pedersen, L. Particle mesh Ewald: An Nlog(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089-10092 (1993).
-
(1993)
J. Chem. Phys
, vol.98
, pp. 10089-10092
-
-
Darden, T.D.Y.1
Pedersen, L.2
|